Literature DB >> 20045665

Tuberculosis research: going forward with a powerful "translational systems biology" approach.

Judy Day1, Larry S Schlesinger, Avner Friedman.   

Abstract

Due to the complexity of the immune response to a Mycobacterium tuberculosis infection, identifying new, effective therapies and vaccines to combat it has been a problematic issue. Although many advances have been made in understanding particular mechanisms involved, they have, to date, proved insufficient to provide real breakthroughs in this area of tuberculosis research. The term "Translational Systems Biology" has been formally proposed to describe the use of experimental findings combined with mathematical modeling and/or engineering principles to understand complex biological processes in an integrative fashion for the purpose of enhancing clinical practice. This opinion piece discusses the importance of using a Translational Systems Biology approach for tuberculosis research as a means by which to go forward with the potential for significant breakthroughs to occur.

Entities:  

Mesh:

Year:  2010        PMID: 20045665      PMCID: PMC2819545          DOI: 10.1016/j.tube.2009.12.002

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  7 in total

Review 1.  Systems biology of persistent infection: tuberculosis as a case study.

Authors:  Douglas Young; Jaroslav Stark; Denise Kirschner
Journal:  Nat Rev Microbiol       Date:  2008-06-09       Impact factor: 60.633

2.  Modeling the immune rheostat of macrophages in the lung in response to infection.

Authors:  Judy Day; Avner Friedman; Larry S Schlesinger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

Review 3.  A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment.

Authors:  H D Hollis Showalter; William A Denny
Journal:  Tuberculosis (Edinb)       Date:  2008-08       Impact factor: 3.131

Review 4.  Mathematical and computational approaches can complement experimental studies of host-pathogen interactions.

Authors:  Denise E Kirschner; Jennifer J Linderman
Journal:  Cell Microbiol       Date:  2009-04       Impact factor: 3.715

5.  Challenges and rewards on the road to translational systems biology in acute illness: four case reports from interdisciplinary teams.

Authors:  Gary An; C Anthony Hunt; Gilles Clermont; Edmund Neugebauer; Yoram Vodovotz
Journal:  J Crit Care       Date:  2007-06       Impact factor: 3.425

Review 6.  Translational systems biology of inflammation.

Authors:  Yoram Vodovotz; Marie Csete; John Bartels; Steven Chang; Gary An
Journal:  PLoS Comput Biol       Date:  2008-04-25       Impact factor: 4.475

7.  Dynamics and potential impact of the immune response to chronic myelogenous leukemia.

Authors:  Peter S Kim; Peter P Lee; Doron Levy
Journal:  PLoS Comput Biol       Date:  2008-06-20       Impact factor: 4.475

  7 in total
  5 in total

1.  A physiologically based pharmacokinetic model of rifampin in mice.

Authors:  Michael A Lyons; Brad Reisfeld; Raymond S H Yang; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2013-01-28       Impact factor: 5.191

Review 2.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

3.  Systems biology of fungal infection.

Authors:  Fabian Horn; Thorsten Heinekamp; Olaf Kniemeyer; Johannes Pollmächer; Vito Valiante; Axel A Brakhage
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

4.  Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses.

Authors:  Stephen N Crooke; Inna G Ovsyannikova; Gregory A Poland; Richard B Kennedy
Journal:  Exp Gerontol       Date:  2019-06-13       Impact factor: 4.253

Review 5.  Mycobacterial virulence: impact on immunogenicity and vaccine research.

Authors:  Vera M Kroesen; Jan Madacki; Wafa Frigui; Fadel Sayes; Roland Brosch
Journal:  F1000Res       Date:  2019-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.